Testing CTH120 for men with Fragile X syndrome
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests a new medicine called CTH120 to see if it is safe and helpful for adult men with Fragile X syndrome. You may be able to join if you meet certain health and age requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 45 years old.
- You have a confirmed diagnosis of Fragile X syndrome with a specific genetic test result.
- You have a weight between 50 kg (110 lbs) and 100 kg (220 lbs), and a body mass index (BMI) between 18.5 and 32.
- A parent or reliable caregiver must be able to come with you to all study visits and help the study team.
- You do not have a current diagnosis of severe autism or other major psychiatric condition, and you have not had seizures or epilepsy in the past.
- You are not taking certain medications, or you are on stable doses as allowed by the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medicine called SPG601 to see if it can help with Fragile X syndrome symptoms in adult males. It also checks how safe the medicine is.
This trial tests an investigational medicine called MRM-3379 in males with Fragile X syndrome. It looks at how the medicine affects thinking and behavior over time.
This study tests whether a daily dose of CBD (a cannabis compound) can change brain activity in people with Fragile X syndrome. It also includes a healthy control group to compare results.
This study uses special eye imaging to look at changes in the brain and eyes of people with creatine transporter deficiency (a condition that affects brain energy) or fragile X syndrome. It aims to find a way to see these brain changes without needing a biopsy or spinal tap.
This trial tests if cannabidiol (CBD) can help with anxiety and improve brain function in people with Fragile X syndrome. Participants will receive CBD or a placebo, and may have brain scans (MRI) or magnetic stimulation (TMS) to see how it works.
This study explores how people with Down syndrome or Fragile X syndrome learn to trust others. It uses simple tasks and a brain scan (MRI) to compare their responses with those of typically developing children and young adults.
Hear when a new Fragile X Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.